Abstract
Background
The pathophysiological mechanisms responsible for the disparity in stroke risk between asymptomatic and symptomatic carotid stenosis patients are not fully understood. The functionally important reticulated platelet fraction and reticulocytes could play a role.
Objectives
We performed a prospective, multi-centre, observational analytical study comparing full blood count parameters and platelet production/turnover/activation markers in patients with asymptomatic versus recently symptomatic moderate (≥ 50–69%) or severe (≥ 70–99%) carotid stenosis.
Patients/methods
Data from 34 asymptomatic patients were compared with 43 symptomatic patients in the ‘early phase’ (≤ 4 weeks) and 37 of these patients in the ‘late phase’ (≥ 3 months) after TIA/ischaemic stroke. Reticulated platelets were quantified by whole blood flow cytometry and reticulated platelets and red cell reticulocytes by ‘automated assays’ (Sysmex XE-2100™). Bilateral simultaneous transcranial Doppler ultrasound monitoring classified patients as micro-embolic signal (MES)+ve or MES−ve.
Results
Mean platelet count was higher in early (216 × 109/L; P = 0.04) and late symptomatic (219 × 109/L; P = 0.044) than asymptomatic patients (194 × 109/L). Mean platelet volume was higher in early symptomatic than asymptomatic patients (10.8 vs. 10.45 fl; P = 0.045). Automated assays revealed higher % reticulated platelet fractions in early (5.78%; P < 0.001) and late symptomatic (5.11%; P = 0.01) than asymptomatic patients (3.48%). Red cell reticulocyte counts were lower in early (0.92%; P = 0.035) and late symptomatic (0.93%; P = 0.036) than asymptomatic patients (1.07%). The automated % reticulated platelet fraction was also higher in early symptomatic than asymptomatic MES−ve patients (5.7 vs. 3.55%; P = 0.001).
Discussion
The combination of increased platelet counts and a shift towards production of an increased population of larger, young, reticulated platelets could contribute to a higher risk of first or recurrent cerebrovascular events in recently symptomatic versus asymptomatic carotid stenosis, including those who are MES−ve.
Similar content being viewed by others
References
Harrison P, Robinson MS, Mackie IJ, Machin SJ (1997) Reticulated platelets. Platelets 8:379–383
Lunetta P, Penttila A (1997) Pulmonary platelet production: physical fragmentation and platelet territories. Eur J Haematol 59:63–64
Hoffmann JJ (2014) Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 52:1107–1117
Ingram M, Coopersmith A (1969) Reticulated platelets following acute blood loss. Br J Haematol 17:225–229
Ault KA, Knowles C (1995) In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 23:996–1001
Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS (1992) The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 98:637–646
Lakkis N, Dokainish H, Abuzahra M, Tsyboulev V, Jorgensen J, De Leon AP, Saleem A (2004) Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 44:2091–2093
Eisen A, Lerman-Shivek H, Perl L, Rechavia E, Leshem-Lev D, Zemer-Wassercug N, Dadush O, Kazum S, Codner P, Kornowski R, Lev EI (2014) Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor. J Thromb Thrombolysis 40:70–75
Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52:743–749
Cesari F, Marcucci R, Gori AM, Caporale R, Fanelli A, Casola G, Balzi D, Barchielli A, Valente S, Giglioli C, Gensini GF, Abbate R (2013) Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study. Thromb Haemost 109:846–853
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ (2004) Platelet degranulation and monocyte–platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 125:777–787
Smith NM, Pathansali R, Bath PM (2002) Altered megakaryocyte–platelet–haemostatic axis in patients with acute stroke. Platelets 13:113–120
Nakamura T, Uchiyama S, Yamazaki M, Okubo K, Takakuwa Y, Iwata M (2002) Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res 106:171–177
Spence JD, Coates V, Li H, Tamayo A, Munoz C, Hackam DG, DiCicco M, DesRoches J, Bogiatzi C, Klein J, Madrenas J, Hegele RA (2010) Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 67:180–186
Spence JD, Tamayo A, Lownie SP, Ng WP, Ferguson GG (2005) Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 36:2373–2378
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Machin SJ, Brown MM (2005) Increased platelet count and leucocyte–platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J Neurol Neurosurg Psychiatry 76:1249–1254
Cha JK, Jeong MH, Jang JY, Bae HR, Lim YJ, Kim JS, Kim SH, Kim JW (2003) Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis 16:376–382
Jurk K, Ritter MA, Schriek C, Van Aken H, Droste DW, Ringelstein EB, Kehrel BE (2010) Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis. Thromb Haemost 103:1193–1202
Kinsella JA, Tobin WO, Tierney S, Feeley TM, Egan B, Collins DR, Coughlan T, O’Neill D, Harbison J, Madhavan P, Moore DJ, O’Neill SM, Colgan MP, Doherty CP, Murphy RP, Saqqur M, Moran N, Hamilton G, McCabe DJ (2013) Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost 11:1407–1416
Lukasik M, Rozalski M, Luzak B, Michalak M, Ambrosius W, Watala C, Kozubski W (2013) Enhanced platelet-derived microparticle formation is associated with carotid atherosclerosis in convalescent stroke patients. Platelets 24:63–70
Rocca B, Secchiero P, Ciabattoni G, Ranelletti FO, Catani L, Guidotti L, Melloni E, Maggiano N, Zauli G, Patrono C (2002) Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci USA 99:7634–7639
Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF, Kleiman NS (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 5:490–496
Ney PA (2011) Normal and disordered reticulocyte maturation. Curr Opin Hematol 18:152–157
Koury MJ, Sawyer ST, Brandt SJ (2002) New insights into erythropoiesis. Curr Opin Hematol 9:93–100
Sidhu PS, Allan PL (1997) Ultrasound assessment of internal carotid artery stenosis. Clin Radiol 52:654–658
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, Gocke J, Hertzberg BS, Katarick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler E, Society of Radiologists in U (2003) Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis—Society of Radiologists in Ultrasound consensus conference. Ultrasound Q 19:190–198
Silvennoinen HM, Ikonen S, Soinne L, Railo M, Valanne L (2007) CT angiographic analysis of carotid artery stenosis: comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. AJNR Am J Neuroradiol 28:97–103
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
European Stroke Organisation (2008) (ESO) Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 25:457–507
Kinsella JA, Tobin WO, Hamilton G, McCabe DJ (2013) Platelet activation, function, and reactivity in atherosclerotic carotid artery stenosis: a systematic review of the literature. Int J Stroke 8:451–464
Harrison PGA (2016) Studies on mean platelet volume (MPV)—new editorial policy. Platelets 27:605–606
Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307–315
McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ (2004) Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 126:861–869
Briggs C, Kunka S, Hart D, Oguni S, Machin SJ (2004) Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 126:93–99
Daly ME (2011) Determinants of platelet count in humans. Haematologica 96:10–13
Ozkan B, Arik OZ, Gozukara MY, Sahin DY, Topal S, Uysal OK, Elbasan Z, Epceliden T, Cayli M, Gur M (2014) Mean platelet volume is related with ischemic stroke in patients with sinus rhythm. Blood Coagul Fibrinolysis 27:490–493
Tamer D, Fevzi Y, Deniz AE, Cemil K, Fatih B, Cihat Y, Serkan YM, Ali CM, Evvah KM (2013) The value of serum mean platelet volume in ischaemic stroke patient. J Pak Med Assoc 63:1509–1510
Bath P, Algert C, Chapman N, Neal B, Group PC (2004) Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 35:622–626
Li B, Liu X, Cao ZG, Li Y, Liu TM, Wang RT (2014) Elevated mean platelet volume is associated with silent cerebral infarction. Intern Med J 44:653–657
van der Loo B, Martin JF (1999) A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 19:672–679
Trowbridge EA, Slater DN, Kishk YT, Woodcock BW, Martin JF (1984) Platelet production in myocardial infarction and sudden cardiac death. Thromb Haemost 52:167–171
Molloy J, Markus HS (1999) Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 30:1440–1443
Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, Bornstein NM, Schaafsma A (2010) Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 9:663–671
Topakian R, King A, Kwon SU, Schaafsma A, Shipley M, Markus HS, Investigators A (2011) Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology 77:751–758
Acknowledgements
The remaining HEIST study group are: Tierney S FRCSI, Feely M FRCSI and Egan B FRCSI (Dept. of Vascular Surgery, AMNCH, Dublin, Ireland); Murphy SM FRCPI and Walsh RA FRCPI (Dept. of Neurology and Stroke Service, AMNCH, Dublin, and Academic Unit of Neurology, Trinity College Dublin, Ireland); Coughlan T FRCPI, Collins DR MD and O’Neill D MD (Dept. of Age-Related Healthcare and Stroke Service, AMNCH, Dublin, Ireland); Harbison JA MD (Dept. of Medicine for the Elderly/Stroke Service, St James’s Hospital, Dublin and Trinity College Dublin, Ireland), Madhavan P FRCS (Ed), O’Neill SM MCh and Colgan M-P MD (Dept. of Vascular Surgery, St James’s Hospital, Dublin, Ireland); Cox D PhD, Moran N PhD (Dept. of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland), Hamilton G (University Dept. of Surgery, Royal Free Hampstead NHS Trust, London, UK). All HEIST collaborators qualified for authorship as they contributed to data acquisition or study design, and all critically appraised the manuscript for important intellectual content.
Dr Murphy’s research was funded by the Trinity College Dublin Innovation Bursary, the Meath Foundation, Ireland, Joint IICN/Merck Serono Fellowship in Neuroscience, The Vascular Neurology Research Foundation, Ireland, and by an unrestricted educational grant from Bayer HealthCare Ireland, and Verum Diagnostica, GmbH. Dr. Lim’s research was funded by the Meath Foundation, Ireland, The Irish Institute of Clinical Neuroscience (IICN)/Novartis Ireland Fellowship Grant, The Irish Heart Foundation Stroke Prevention Bursary, and by unrestricted educational grant funding from Biogen Idec Ireland. None of the above charities or funding bodies had any influence on design or conduct of this study, or had any influence on the decision to submit the final manuscript for publication. All authors critically reviewed and approved the final submitted manuscript. The manuscript has not been submitted elsewhere and has not been published elsewhere in whole or in part, except as an abstract.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Ethical standard
The study design and research protocol was approved by the Local Research Ethics Committee (Project/LREC Reference: 2011/31/02).
Rights and permissions
About this article
Cite this article
Murphy, S.J.X., Lim, S.T., Kinsella, J.A. et al. Increased platelet count and reticulated platelets in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic signal-negative patient subgroups: results from the HaEmostasis In carotid STenosis (HEIST) study. J Neurol 265, 1037–1049 (2018). https://doi.org/10.1007/s00415-018-8797-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-018-8797-8